1Bayes-Genis A,Conover CA,Schwartz RS.The insulin-like growth factor axis-a review of atherosclerosis and restenosis[J].Circ Res,2000,86(2):125-130.
2Gibbons CH,Dzau VJ.Molecular Therapies for Vascular Disease[J].Science,1996,272(5262):689.
3Faries PL,Rohan DI,Wyears MC,et al.Valcular smooth muscle cells derived from atherosclerotic human arteries exhibit greater adhesion,migration,and proliferation than venous cells[J].J Surg Res,2002,104(1):22-28.
4Weiser-Evans MC,Quinn BE,Burkard MR,et al.Transient reexpression of an embryonic autonomus growth phenotype by adult carotid artery smooth muscle cells after vascular injury[J].JCell Physiol,2000,182(1):12-33.
5Imai Y,Clemmons DR.Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I[J].Endocrinology,1999,140(9):4228-4235.
6Koyama H,Nishizawa Y,Hosoi M,et al.The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-1ike growth factor-l,possible invo1vement of cyclindependent kinase 2[J].Cir Res,1996,79(4):757-764.
7Thommoles KB,Hoppe J,Vetter H,et al.The synergistic effect of PDGF-AA and IGF-l on SMC pro1iferation might be explained by the differential activation of their intracellular signaling pathways[J].Exp Cell Res,1996,26(1):59-66.
9Bai HZ,Pollman MJ,Inish Y,et al.Regulation of vascular smooth muscle cell apotosis:modulation of BAD by a phosphatidylinositol 3-kinase-dependent pathway[J].Circ Res,1999,85(3):229-237.
10Okura Y,Itabe H,Ono K,et al.Expression of insulin-like growth factor-1 in vascular smooth muscle cells is associated with oxidized LDL in human atherosclerotic plaque[J].Atherosclerosis Supplements,2003,4(2):63.
10Arai Y,Hirose N,Yam anmura K,et al.Serum insulin-like grow factor-1 in centenarians implication of IGF-1 as a rapid turmover protein[J].Gerontol A Biol Sci Med Sci,2001,56(2):79-82.
